Pay in 4 interest-free payments of $7.09 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Clinical trial outcomes reflect sponsor-prepared product under controlled study conditions and may not translate to other settings
Efficacy and tolerability of exenatide monotherapy over 24 weeks in antidiabetic drug-naive patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, parallel-group study
10.1016/j.cbi.2019.108777 45 KimJ
740,741 Glutamate transporter modulator ceftriaxone or N-acetylcysteine stabilize the levels of xCT and reduce infarct volume and neurological deficits in rats within 24 h after stroke
US$ 25.15
US$ 28.61
US$ 24.54
US$ 25.03
